BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lakatos PL, Lakatos L. Risk for colorectal cancer in ulcerative colitis: Changes, causes and management strategies. World J Gastroenterol 2008; 14(25): 3937-3947 [PMID: 18609676 DOI: 10.3748/wjg.14.3937] [Cited by in CrossRef: 273] [Cited by in F6Publishing: 293] [Article Influence: 18.2] [Reference Citation Analysis]
Number Citing Articles
1 Rasulov AO, Kulikov AE, Madyarov JM, Rasulov ZR. Colorectal cancer in ulcerative colitis (review). Koloproktologiâ 2023;22:138-146. [DOI: 10.33878/2073-7556-2023-22-1-138-146] [Reference Citation Analysis]
2 Al-Rashedy M, Mukherjee T, Askari A, Gurjar S. A systematic review of outcomes and quality of life after ileorectal anastomosis for ulcerative colitis. Arab J Gastroenterol 2023:S1687-1979(23)00008-4. [PMID: 36813579 DOI: 10.1016/j.ajg.2023.01.007] [Reference Citation Analysis]
3 Özdemir BH. Hypercholesterolemia Influences the Progression of Cancer by Changing the Biomolecular and Immunological Status of the Tumor Microenvironment. Handbook of Cancer and Immunology 2023. [DOI: 10.1007/978-3-030-80962-1_107-1] [Reference Citation Analysis]
4 Henbrey R. The Management of Colorectal Cancer. Stoma Care Specialist Nursing: A Guide for Clinical Practice 2023. [DOI: 10.1007/978-3-031-07799-9_5] [Reference Citation Analysis]
5 Muangthong T, Chusangnin P, Hassametto A, Tanomrat R, Suwannalert P. Thioredoxin Reductase-1 as a Potential Biomarker in Fibroblast-Associated HCT116 Cancer Cell Progression and Dissemination in a Zebrafish Model. Cancers (Basel) 2022;15. [PMID: 36612053 DOI: 10.3390/cancers15010056] [Reference Citation Analysis]
6 Rezazadeh F, Ramos N, Saliganan A, Al-hallak N, Chen K, Mohamad B, Wiesend WN, Viola NT. Detection of IL23p40 via Positron Emission Tomography Visualized Inflammatory Bowel Disease.. [DOI: 10.1101/2022.11.30.518419] [Reference Citation Analysis]
7 Al-mterin MA, Murshed K, Elkord E. PD-1 expression, among other immune checkpoints, on tumor-infiltrating NK and NKT cells is associated with longer disease-free survival in treatment-naïve CRC patients. Cancer Immunol Immunother 2022. [DOI: 10.1007/s00262-022-03337-8] [Reference Citation Analysis]
8 Turan M, Durmus F. UC-NfNet: Deep learning-enabled assessment of ulcerative colitis from colonoscopy images. Medical Image Analysis 2022;82:102587. [DOI: 10.1016/j.media.2022.102587] [Reference Citation Analysis]
9 Yerlikaya S, Djamgoz MB. Oleamide, a Sleep-Inducing Compound: Effects on Ion Channels and Cancer. Bioelectricity 2022;4:136-144. [DOI: 10.1089/bioe.2022.0010] [Reference Citation Analysis]
10 Kobayashi S, Shieh J, Ruiz de Sabando A, Kim J, Liu Y, Zee SY, Prasanna P, Bialkowska AB, Saltz JH, Yang VW. Deep learning-based approach to the characterization and quantification of histopathology in mouse models of colitis. PLoS ONE 2022;17:e0268954. [DOI: 10.1371/journal.pone.0268954] [Reference Citation Analysis]
11 Lee H, Lee H, Chang J. Inflammatory Cytokine: An Attractive Target for Cancer Treatment. Biomedicines 2022;10:2116. [DOI: 10.3390/biomedicines10092116] [Reference Citation Analysis]
12 Chakroborty D, Goswami S, Fan H, Frankel WL, Basu S, Sarkar C. Neuropeptide Y, a paracrine factor secreted by cancer cells, is an independent regulator of angiogenesis in colon cancer. Br J Cancer 2022. [PMID: 35902640 DOI: 10.1038/s41416-022-01916-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Dutta D, He Y, Saha A, Arvanitis M, Battle A, Chatterjee N. Aggregative trans-eQTL analysis detects trait-specific target gene sets in whole blood. Nat Commun 2022;13:4323. [PMID: 35882830 DOI: 10.1038/s41467-022-31845-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kommuru S, Aziz SN, Sagireddy S, Kaur G, Rijal S, Loh CC, Ibrahim Y, Patel V. Risk Factors for Colorectal Cancer in Inpatients With Ulcerative Colitis: A Nationwide Cross-Sectional Analysis. Cureus 2022. [DOI: 10.7759/cureus.27114] [Reference Citation Analysis]
15 Lee Y, Onishi Y, McPherson L, Kietrys AM, Hebenbrock M, Jun YW, Das I, Adimoolam S, Ji D, Mohsen MG, Ford JM, Kool ET. Enhancing Repair of Oxidative DNA Damage with Small-Molecule Activators of MTH1. ACS Chem Biol 2022. [PMID: 35830623 DOI: 10.1021/acschembio.2c00038] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Borowczak J, Szczerbowski K, Maniewski M, Kowalewski A, Janiczek-polewska M, Szylberg A, Marszałek A, Szylberg Ł. The Role of Inflammatory Cytokines in the Pathogenesis of Colorectal Carcinoma—Recent Findings and Review. Biomedicines 2022;10:1670. [DOI: 10.3390/biomedicines10071670] [Reference Citation Analysis]
17 Fajardo P, Taskova M, Martín-Serrano MA, Hansen J, Slott S, Jakobsen AK, Wibom ML, Salegi B, Muñoz A, Barbachano A, Sharma A, Gubatan JM, Habtezion A, Sanz-Ezquerro JJ, Astakhova K, Cuenda A. p38γ and p38δ as biomarkers in the interplay of colon cancer and inflammatory bowel diseases. Cancer Commun (Lond) 2022. [PMID: 35796643 DOI: 10.1002/cac2.12331] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Szigeti KA, Kalmár A, Galamb O, Valcz G, Barták BK, Nagy ZB, Zsigrai S, Felletár I, V. Patai Á, Micsik T, Papp M, Márkus E, Tulassay Z, Igaz P, Takács I, Molnár B. Global DNA hypomethylation of colorectal tumours detected in tissue and liquid biopsies may be related to decreased methyl-donor content. BMC Cancer 2022;22. [DOI: 10.1186/s12885-022-09659-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Tsai L, Chung C, Lin C, Su S, Kuo F, Liu J, Chen K, Ho L, Kuo C, Chang C, Lin M, Chu N, Lee C, Hsieh C, Hung Y, Hsieh P, Lin F, Lu C, Chien W. Traditional Chinese medicine attenuates hospitalization and mortality risks in diabetic patients with carcinoma in situ in Taiwan. Integrative Medicine Research 2022;11:100831. [DOI: 10.1016/j.imr.2021.100831] [Reference Citation Analysis]
20 Sasson AN, Sheehan G, Yu A, Gupta A, Ling K, Kochar B, Ananthakrishnan AN. Yield and Predictors of Surveillance Colonoscopies in Older Adults With Long-standing Ulcerative Colitis. Clin Gastroenterol Hepatol 2022;20:e1353-64. [PMID: 34425278 DOI: 10.1016/j.cgh.2021.08.019] [Reference Citation Analysis]
21 Kobayashi S, Shieh J, de Sabando AR, Kim J, Liu Y, Zee SY, Prasanna P, Bialkowska AB, Saltz JH, Yang VW. Deep learning-based approach for the characterization and quantification of histopathology in mouse models of colitis.. [DOI: 10.1101/2022.05.12.491690] [Reference Citation Analysis]
22 Ma F, Sun M, Song Y, Wang A, Jiang S, Qian F, Mu G, Tuo Y. Lactiplantibacillus plantarum-12 Alleviates Inflammation and Colon Cancer Symptoms in AOM/DSS-Treated Mice through Modulating the Intestinal Microbiome and Metabolome. Nutrients 2022;14. [PMID: 35565884 DOI: 10.3390/nu14091916] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
23 Abdel-Wahab BA, Alkahtani SA, Alqahtani AA, Hassanein EHM. Umbelliferone ameliorates ulcerative colitis induced by acetic acid via modulation of TLR4/NF-κB-p65/iNOS and SIRT1/PPARγ signaling pathways in rats. Environ Sci Pollut Res Int 2022;29:37644-59. [PMID: 35066822 DOI: 10.1007/s11356-021-18252-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 López-Siles M, Camprubí-Font C, Gómez Del Pulgar EM, Sabat Mir M, Busquets D, Sanz Y, Martinez-Medina M. Prevalence, Abundance, and Virulence of Adherent-Invasive Escherichia coli in Ulcerative Colitis, Colorectal Cancer, and Coeliac Disease. Front Immunol 2022;13:748839. [PMID: 35359974 DOI: 10.3389/fimmu.2022.748839] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 . Barriers toward Colorectal Cancer Screening among Public in Saudi Arabia. EJMHS 2022. [DOI: 10.34104/ejmhs.022.055063] [Reference Citation Analysis]
26 Schwarzfischer M, Rogler G. The Intestinal Barrier—Shielding the Body from Nano- and Microparticles in Our Diet. Metabolites 2022;12:223. [DOI: 10.3390/metabo12030223] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
27 Carvello M, Bellato V, Maroli A, Hart A, Danese S, Warusavitarne J, Spinelli A. A Multidisciplinary Approach to Rectal Cancer Treatment in Ulcerative Colitis Results in High Rate of Restorative Minimally Invasive Surgery. J Crohns Colitis 2022;16:244-50. [PMID: 34346483 DOI: 10.1093/ecco-jcc/jjab139] [Reference Citation Analysis]
28 Essa N, O'Connell F, Prina-Mello A, O'Sullivan J, Marcone S. Gold nanoparticles and obese adipose tissue microenvironment in cancer treatment. Cancer Lett 2022;525:1-8. [PMID: 34662546 DOI: 10.1016/j.canlet.2021.10.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
29 Wu B, Sodji QH, Oyelere AK. Inflammation, Fibrosis and Cancer: Mechanisms, Therapeutic Options and Challenges. Cancers (Basel) 2022;14. [PMID: 35158821 DOI: 10.3390/cancers14030552] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
30 Sauceda C, Bayne C, Sudqi K, Gonzalez A, Dulai PS, Knight R, Gonzalez DJ, Gonzalez CG. Stool multi-omics for the study of host-microbe interactions in inflammatory bowel disease. Gut Microbes 2022;14:2154092. [PMID: 36503356 DOI: 10.1080/19490976.2022.2154092] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Mahmood A, Srivastava R. Etiology of cancer. Understanding Cancer 2022. [DOI: 10.1016/b978-0-323-99883-3.00008-1] [Reference Citation Analysis]
32 Yun B, King M, Draz MS, Kline T, Rodriguez-Palacios A. Oxidative reactivity across kingdoms in the gut: Host immunity, stressed microbiota and oxidized foods. Free Radic Biol Med 2022;178:97-110. [PMID: 34843918 DOI: 10.1016/j.freeradbiomed.2021.11.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
33 Huang GZ, Chen ZQ, Wu J, Shao TR, Zou C, Ai YL, Lv XZ. Pan-Cancer Analyses of the Tumor Microenvironment Reveal That Ubiquitin-Conjugating Enzyme E2C Might Be a Potential Immunotherapy Target. J Immunol Res 2021;2021:9250207. [PMID: 34950739 DOI: 10.1155/2021/9250207] [Reference Citation Analysis]
34 Kazemi M, Peymani M. Expression of Th17 axis as a biomarker panel in diagnosis and prognosis of colorectal cancer. Gene Reports 2021;25:101363. [DOI: 10.1016/j.genrep.2021.101363] [Reference Citation Analysis]
35 Frigerio S, Lartey DA, D'Haens GR, Grootjans J. The Role of the Immune System in IBD-Associated Colorectal Cancer: From Pro to Anti-Tumorigenic Mechanisms. Int J Mol Sci 2021;22:12739. [PMID: 34884543 DOI: 10.3390/ijms222312739] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
36 Abumustafa W, Zamer BA, Khalil BA, Hamad M, Maghazachi AA, Muhammad JS. Protein arginine N-methyltransferase 5 in colorectal carcinoma: Insights into mechanisms of pathogenesis and therapeutic strategies. Biomed Pharmacother 2021;145:112368. [PMID: 34794114 DOI: 10.1016/j.biopha.2021.112368] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
37 Ba H, Jiang R, Zhang M, Yin B, Wang J, Li Z, Li B, Zhou X. Suppression of Transmembrane Tumor Necrosis Factor Alpha Processing by a Specific Antibody Protects Against Colitis-Associated Cancer. Front Immunol 2021;12:687874. [PMID: 34675913 DOI: 10.3389/fimmu.2021.687874] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
38 D. Santos M. Restorative Proctocolectomy: When to Propose and When to Avoid. Current Topics in Colorectal Surgery [Working Title] 2021. [DOI: 10.5772/intechopen.98987] [Reference Citation Analysis]
39 Mukherjee N, Ji N, Tan X, Lin CL, Rios E, Chen CL, Huang T, Svatek RS. Bladder tumor ILC1s undergo Th17-like differentiation in human bladder cancer. Cancer Med 2021;10:7101-10. [PMID: 34496133 DOI: 10.1002/cam4.4243] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
40 Kanani H, Gandhi N, Sheth A, Kulkarni N. Multiple primary malignant neoplasms: a case of colonic adenocarcinoma and non-Hodgkin's lymphoma on a background of ulcerative colitis. Ann R Coll Surg Engl 2021. [PMID: 34482743 DOI: 10.1308/rcsann.2021.0065] [Reference Citation Analysis]
41 Guo J, Liao M, Wang J. TLR4 signaling in the development of colitis-associated cancer and its possible interplay with microRNA-155. Cell Commun Signal 2021;19:90. [PMID: 34479599 DOI: 10.1186/s12964-021-00771-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
42 Cherkasova V, Kovalchuk O, Kovalchuk I. Cannabinoids and Endocannabinoid System Changes in Intestinal Inflammation and Colorectal Cancer. Cancers (Basel) 2021;13:4353. [PMID: 34503163 DOI: 10.3390/cancers13174353] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
43 Sun R, He XY, Mei C, Ou CL. Role of exosomal long non-coding RNAs in colorectal cancer. World J Gastrointest Oncol 2021; 13(8): 867-878 [PMID: 34457192 DOI: 10.4251/wjgo.v13.i8.867] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
44 Rana S, Maurya S, Chadrasekhar H, Srikanth CV. Molecular determinants of peaceful coexistence versus invasiveness of non-Typhoidal Salmonella: Implications in long-term side-effects. Mol Aspects Med 2021;:100997. [PMID: 34311996 DOI: 10.1016/j.mam.2021.100997] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Applications of Sericin. Sustainable Use of Byproducts from Silk Processing 2021. [DOI: 10.1002/9783527828760.ch3] [Reference Citation Analysis]
46 Cheng KJ, Mejia Mohammed EH, Khong TL, Mohd Zain S, Thavagnanam S, Ibrahim ZA. IL-1α and colorectal cancer pathogenesis: Enthralling candidate for anti-cancer therapy. Crit Rev Oncol Hematol 2021;163:103398. [PMID: 34147647 DOI: 10.1016/j.critrevonc.2021.103398] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
47 Alkhayyat M, Abureesh M, Gill A, Khoudari G, Abou Saleh M, Mansoor E, Regueiro M. Lower Rates of Colorectal Cancer in Patients With Inflammatory Bowel Disease Using Anti-TNF Therapy. Inflamm Bowel Dis 2021;27:1052-60. [PMID: 33051651 DOI: 10.1093/ibd/izaa252] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
48 Yalchin M, Baker AM, Graham TA, Hart A. Predicting Colorectal Cancer Occurrence in IBD. Cancers (Basel) 2021;13:2908. [PMID: 34200768 DOI: 10.3390/cancers13122908] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
49 Deb J, Lakshman TR, Ghosh I, Jana SS, Paine TK. Mechanistic studies of in vitro anti-proliferative and anti-inflammatory activities of the Zn(ii)-NSAID complexes of 1,10-phenanthroline-5,6-dione in MDA-MB-231 cells. Dalton Trans 2020;49:11375-84. [PMID: 32766641 DOI: 10.1039/d0dt01721c] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
50 Núñez F P, Krugliak Cleveland N, Quera R, Rubin DT. Evolving role of endoscopy in inflammatory bowel disease: Going beyond diagnosis. World J Gastroenterol 2021; 27(20): 2521-2530 [PMID: 34092973 DOI: 10.3748/wjg.v27.i20.2521] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
51 Aranda-Anzaldo A, Dent MAR. Is cancer a disease set up by cellular stress responses? Cell Stress Chaperones 2021;26:597-609. [PMID: 34031811 DOI: 10.1007/s12192-021-01214-4] [Reference Citation Analysis]
52 Nishiguchi R, Basu S, Staab HA, Ito N, Zhou XK, Wang H, Ha T, Johncilla M, Yantiss RK, Montrose DC, Dannenberg AJ. Dietary interventions to prevent high-fructose diet-associated worsening of colitis and colitis-associated tumorigenesis in mice. Carcinogenesis 2021;42:842-52. [PMID: 33513602 DOI: 10.1093/carcin/bgab007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
53 Xia Z, Zhang G, Wang C, Feng Y. The role of FKBP51 in the prognosis of ulcerative colitis-associated colorectal cancer. Adv Med Sci 2021;66:89-97. [PMID: 33461100 DOI: 10.1016/j.advms.2021.01.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
54 Agazzi S, Lenti MV, Klersy C, Strada E, Pozzi L, Rovedatti L, Bardone M, Mauro A, Costetti M, Costa S, De Grazia F, Di Sabatino A. Incidence and risk factors for preneoplastic and neoplastic lesions of the colon and rectum in patients under 50 referred for colonoscopy. Eur J Intern Med 2021;87:36-43. [PMID: 33610414 DOI: 10.1016/j.ejim.2021.02.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
55 Yuan Q, Gu J, Zhang J, Liu S, Wang Q, Tian T, Chen Z, Zhang J. MyD88 in myofibroblasts enhances colitis-associated tumorigenesis via promoting macrophage M2 polarization. Cell Rep 2021;34:108724. [PMID: 33535045 DOI: 10.1016/j.celrep.2021.108724] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 9.0] [Reference Citation Analysis]
56 Moreno Moraleda I, Lázaro Sáez M, Diéguez Castillo C, Hernández Martínez Á. Inflammatory bowel disease and inherited colorectal cancer: Is there a genetic link? Gastroenterología y Hepatología (English Edition) 2021;44:133-134. [DOI: 10.1016/j.gastre.2020.05.012] [Reference Citation Analysis]
57 Lightner AL, Vogler S, McMichael J, Jia X, Regueiro M, Qazi T, Steele SR. Dysplastic Progression to Adenocarcinoma is Equivalent in Ulcerative Colitis and Crohn's Disease. J Crohns Colitis 2021;15:24-34. [PMID: 32592468 DOI: 10.1093/ecco-jcc/jjaa133] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
58 Mahapatro M, Erkert L, Becker C. Cytokine-Mediated Crosstalk between Immune Cells and Epithelial Cells in the Gut. Cells 2021;10:111. [PMID: 33435303 DOI: 10.3390/cells10010111] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 12.5] [Reference Citation Analysis]
59 Choo J, Heo G, Pothoulakis C, Im E. Posttranslational modifications as therapeutic targets for intestinal disorders. Pharmacol Res 2021;165:105412. [PMID: 33412276 DOI: 10.1016/j.phrs.2020.105412] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
60 Benlebna M, Balas L, Gaillet S, Durand T, Coudray C, Casas F, Feillet-Coudray C. Potential physio-pathological effects of branched fatty acid esters of hydroxy fatty acids. Biochimie 2021;182:13-22. [PMID: 33412159 DOI: 10.1016/j.biochi.2020.12.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
61 Stellingwerf ME, Bemelman WA, Löwenberg M, Ponsioen CY, D'Haens GR, van Dieren S, Buskens CJ; Parelsnoer Institute, the Dutch Initiative on Crohn, Colitis*a. A nationwide database study on colectomy and colorectal cancer in ulcerative colitis: what is the role of appendectomy? Colorectal Dis 2021;23:64-73. [PMID: 32524670 DOI: 10.1111/codi.15184] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
62 Siddique O, Vaziri H, Anderson JC. Colon Cancer Screening and Surveillance in the IBD Patient. Clinical Gastroenterology 2021. [DOI: 10.1007/978-3-030-81780-0_10] [Reference Citation Analysis]
63 Banday MZ, Sameer AS, Nissar S. Colorectal Cancer and Genetic Polymorphism in Key Regulatory Low Penetrance Genes. Genetic Polymorphism and cancer susceptibility 2021. [DOI: 10.1007/978-981-33-6699-2_5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
64 Sasi S, Singh S, Walia T, Meena RC, Thakur S. Role of MicroRNA In Situ Hybridization in Colon Cancer Diagnosis. Colon Cancer Diagnosis and Therapy 2021. [DOI: 10.1007/978-3-030-63369-1_5] [Reference Citation Analysis]
65 Medina-andrade I, Olguín JE, Rodríguez T, Terrazas LI. The inflammation during colorectal cancer: A friend or a foe? Immunotherapy in Resistant Cancer: From the Lab Bench Work to Its Clinical Perspectives 2021. [DOI: 10.1016/b978-0-12-822028-3.00003-0] [Reference Citation Analysis]
66 Mehrzad J, Dayyani M, Erfanian-Khorasani M. The independent and combined effects of selected risk factors and Arg399Gln XRCC1 polymorphism in the risk of colorectal cancer among an Iranian population. Med J Islam Repub Iran 2020;34:75. [PMID: 33306066 DOI: 10.34171/mjiri.34.75] [Reference Citation Analysis]
67 Zhang H, Wang Y, Liu J, Kuerban K, Li J, Iminjan M, Ye L. Traditional Uyghur medicine Quercus infectoria galls water extract triggers apoptosis and autophagic cell death in colorectal cancer cells. BMC Complement Med Ther 2020;20. [DOI: 10.1186/s12906-020-03167-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
68 Gwyer Findlay E, Sutton G, Ho G. The MARVEL trial: a phase 2b randomised placebo-controlled trial of oral MitoQ in moderate ulcerative colitis. Immunotherapy Advances 2021;1:ltaa002. [DOI: 10.1093/immadv/ltaa002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
69 Mourad AP, De Robles MS, Winn RD. Intestinal T-cell lymphoma presenting as colonic perforation in the setting of ulcerative colitis: a case report. Clin J Gastroenterol 2021;14:176-80. [PMID: 33174156 DOI: 10.1007/s12328-020-01279-1] [Reference Citation Analysis]
70 Tefas C, Mărginean R, Toma V, Petrushev B, Fischer P, Tanțău M, Știufiuc R. Surface-enhanced Raman scattering for the diagnosis of ulcerative colitis: will it change the rules of the game? Anal Bioanal Chem 2021;413:827-38. [PMID: 33161464 DOI: 10.1007/s00216-020-03036-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
71 Dubinsky V, Dotan I, Gophna U. Carriage of Colibactin-producing Bacteria and Colorectal Cancer Risk. Trends in Microbiology 2020;28:874-6. [DOI: 10.1016/j.tim.2020.05.015] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
72 Dutta D, He Y, Saha A, Arvanitis M, Battle A, Chatterjee N. Aggregative trans-eQTL analysis detects trait-specific target gene sets in whole blood.. [DOI: 10.1101/2020.09.29.20204388] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
73 Smith M, Lara OD, O'Cearbhaill R, Knisely A, McEachron J, Gabor L, Carr C, Blank S, Prasad-Hayes M, Frey M, Jee J, Fehniger J, Wang Y, Lee YC, Isani S, Wright JD, Pothuri B. Inflammatory markers in gynecologic oncology patients hospitalized with COVID-19 infection. Gynecol Oncol 2020;159:618-22. [PMID: 33019984 DOI: 10.1016/j.ygyno.2020.09.036] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
74 Zhao Y, Jiang Q. Roles of the Polyphenol-Gut Microbiota Interaction in Alleviating Colitis and Preventing Colitis-Associated Colorectal Cancer. Adv Nutr 2021;12:546-65. [PMID: 32905583 DOI: 10.1093/advances/nmaa104] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 14.3] [Reference Citation Analysis]
75 Ji Y, Tu X, Hu X, Wang Z, Gao S, Zhang Q, Zhang W, Zhang H, Chen W. The role and mechanism of action of RNF186 in colorectal cancer through negative regulation of NF-κB. Cell Signal 2020;75:109764. [PMID: 32882406 DOI: 10.1016/j.cellsig.2020.109764] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
76 San Gabriel PT, Liu Y, Schroder AL, Zoellner H, Chami B. The Role of Thiocyanate in Modulating Myeloperoxidase Activity during Disease. Int J Mol Sci 2020;21:E6450. [PMID: 32899436 DOI: 10.3390/ijms21176450] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
77 Lowery JT, Weber TK, Ahnen DJ, Schroy Iii PC, Levell CL, Smith RA. An action plan to address the rising burden of colorectal cancer in younger adults. Colorectal Cancer 2020;9:CRC24. [DOI: 10.2217/crc-2020-0004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
78 Moreno Moraleda I, Lázaro Sáez M, Diéguez Castillo C, Hernández Martínez Á. Inflammatory bowel disease and inherited colorectal cancer: Is there a genetic link? Gastroenterol Hepatol 2021;44:133-4. [PMID: 32883539 DOI: 10.1016/j.gastrohep.2020.05.014] [Reference Citation Analysis]
79 Jo MJ, Kim BG, Park SH, Kim HJ, Jeong S, Kim BR, Kim JL, Na YJ, Jeong YA, Yun HK, Kim DY, Han J, Heo JY, Yoo YD, Lee DH, Oh SC. Romo1 Inhibition Induces TRAIL-Mediated Apoptosis in Colorectal Cancer. Cancers (Basel) 2020;12:E2358. [PMID: 32825500 DOI: 10.3390/cancers12092358] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
80 Nadeem MS, Kumar V, Al-abbasi FA, Kamal MA, Anwar F. Risk of colorectal cancer in inflammatory bowel diseases. Seminars in Cancer Biology 2020;64:51-60. [DOI: 10.1016/j.semcancer.2019.05.001] [Cited by in Crossref: 72] [Cited by in F6Publishing: 80] [Article Influence: 24.0] [Reference Citation Analysis]
81 De Cicco P, Ercolano G, Ianaro A. The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion. Front Immunol 2020;11:1680. [PMID: 32849585 DOI: 10.3389/fimmu.2020.01680] [Cited by in Crossref: 88] [Cited by in F6Publishing: 96] [Article Influence: 29.3] [Reference Citation Analysis]
82 Liu Y, Burton T, Rayner BS, San Gabriel PT, Shi H, El Kazzi M, Wang X, Dennis JM, Ahmad G, Schroder AL, Gao A, Witting PK, Chami B. The role of sodium thiocyanate supplementation during dextran sodium sulphate-stimulated experimental colitis. Arch Biochem Biophys 2020;692:108490. [PMID: 32721434 DOI: 10.1016/j.abb.2020.108490] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
83 Wolfe AE, Moskowitz JE, Franklin CL, Wiemken TL, Ericsson AC. Interactions of Segmented Filamentous Bacteria (Candidatus Savagella) and bacterial drivers in colitis-associated colorectal cancer development. PLoS One 2020;15:e0236595. [PMID: 32706816 DOI: 10.1371/journal.pone.0236595] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
84 Song CH, Kim N, Nam RH, Choi SI, Lee HN, Surh YJ. 17β-Estradiol supplementation changes gut microbiota diversity in intact and colorectal cancer-induced ICR male mice. Sci Rep 2020;10:12283. [PMID: 32704056 DOI: 10.1038/s41598-020-69112-w] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
85 Scheurlen KM, Billeter AT, O'Brien SJ, Galandiuk S. Metabolic dysfunction and early-onset colorectal cancer - how macrophages build the bridge. Cancer Med 2020;9:6679-93. [PMID: 33624450 DOI: 10.1002/cam4.3315] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
86 Nebbia M, Yassin NA, Spinelli A. Colorectal Cancer in Inflammatory Bowel Disease. Clin Colon Rectal Surg 2020;33:305-17. [PMID: 32968366 DOI: 10.1055/s-0040-1713748] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 7.3] [Reference Citation Analysis]
87 Weir TL, Trikha SRJ, Thompson HJ. Diet and cancer risk reduction: The role of diet-microbiota interactions and microbial metabolites. Semin Cancer Biol 2021;70:53-60. [PMID: 32574813 DOI: 10.1016/j.semcancer.2020.06.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
88 Liu Y(, Burton T, Rayner BS, Gabriel PS, Shi H, Kazzi ME, Wang X, Dennis JM, Ahmad G, Witting PK, Chami B. The role of sodium thiocyanate supplementation during dextran sodium sulphate-stimulated experimental colitis.. [DOI: 10.1101/2020.05.27.117994] [Reference Citation Analysis]
89 Kobelt D, Zhang C, Clayton-Lucey IA, Glauben R, Voss C, Siegmund B, Stein U. Pro-inflammatory TNF-α and IFN-γ Promote Tumor Growth and Metastasis via Induction of MACC1. Front Immunol 2020;11:980. [PMID: 32670264 DOI: 10.3389/fimmu.2020.00980] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
90 Rahmani F, Asgharzadeh F, Avan A, Barneh F, Parizadeh MR, Ferns GA, Ryzhikov M, Ahmadian MR, Giovannetti E, Jafari M, Khazaei M, Hassanian SM. Rigosertib potently protects against colitis-associated intestinal fibrosis and inflammation by regulating PI3K/AKT and NF-κB signaling pathways. Life Sciences 2020;249:117470. [DOI: 10.1016/j.lfs.2020.117470] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
91 Ye Q, Hu Z, Yang M, Qin K, Zhou Y. Effects and mechanisms of Chinese herbal medicine for ulcerative colitis: Protocol for a systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e19768. [PMID: 32311981 DOI: 10.1097/MD.0000000000019768] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
92 Zhou H, Ikeuchi-Takahashi Y, Hattori Y, Onishi H. Nanogels of a Succinylated Glycol Chitosan-Succinyl Prednisolone Conjugate: Release Behavior, Gastrointestinal Distribution, and Systemic Absorption. Int J Mol Sci 2020;21:E2376. [PMID: 32235554 DOI: 10.3390/ijms21072376] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
93 Chang S, Parker GA, Kleinschmidt SE, Olsen GW, Ley CA, Taiwo OA. A Pathology Review of the Lower Gastrointestinal Tract in Relation to Ulcerative Colitis in Rats and Cynomolgus Macaques Treated With Ammonium Perfluorooctanoate. Toxicol Pathol 2020;48:593-602. [PMID: 32186254 DOI: 10.1177/0192623320911606] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
94 Jhang JS, Livneh H, Yang SY, Huang HJ, Chan MWY, Lu MC, Yeh CC, Tsai TY. Decreased risk of colorectal cancer among patients with type 2 diabetes receiving Chinese herbal medicine: a population-based cohort study. BMJ Open Diabetes Res Care 2020;8:e000732. [PMID: 32169932 DOI: 10.1136/bmjdrc-2019-000732] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
95 Chan JCY, Diakos CI, Engel A, Chan DLH, Pavlakis N, Gill A, Clarke SJ. Serum bicarbonate is a marker of peri-operative mortality but is not associated with long term survival in colorectal cancer. PLoS One 2020;15:e0228466. [PMID: 31999779 DOI: 10.1371/journal.pone.0228466] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
96 Adithya G, Madaan V, Gupta R, Jindal S, Govil D. Malignant perforation of sigmoid colon in long-standing ulcerative colitis. Apollo Med 2020;17:46. [DOI: 10.4103/am.am_31_19] [Reference Citation Analysis]
97 Bignold LP. Principles of surgery for tumors. Principles of Tumors 2020. [DOI: 10.1016/b978-0-12-816920-9.00012-2] [Reference Citation Analysis]
98 Stoffel EM, Murphy CC. Epidemiology and Mechanisms of the Increasing Incidence of Colon and Rectal Cancers in Young Adults. Gastroenterology 2020;158:341-53. [PMID: 31394082 DOI: 10.1053/j.gastro.2019.07.055] [Cited by in Crossref: 172] [Cited by in F6Publishing: 176] [Article Influence: 57.3] [Reference Citation Analysis]
99 Domene CE, Volpe P, Almeida Heitor F, Santana AV. Disposable free three port laparoscopic appendectomy – low cost alternative for emergency. GHOA 2020;11:94-98. [DOI: 10.15406/ghoa.2020.11.00421] [Reference Citation Analysis]
100 Walker WA. Colorectal cancer and the microbiome: dysplasia, probiotics, and Fusobacterium nucleatum. Colorectal Neoplasia and the Colorectal Microbiome 2020. [DOI: 10.1016/b978-0-12-819672-4.00005-2] [Reference Citation Analysis]
101 Drewes JL, Domingue JC, Housseau F. Microbiota, mucosal immunity, and Colon cancer. Colorectal Neoplasia and the Colorectal Microbiome 2020. [DOI: 10.1016/b978-0-12-819672-4.00008-8] [Reference Citation Analysis]
102 Ganal-Vonarburg SC, Duerr CU. The interaction of intestinal microbiota and innate lymphoid cells in health and disease throughout life. Immunology 2020;159:39-51. [PMID: 31777064 DOI: 10.1111/imm.13138] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 9.3] [Reference Citation Analysis]
103 Batista S, Gregório AC, Hanada Otake A, Couto N, Costa-Silva B. The Gastrointestinal Tumor Microenvironment: An Updated Biological and Clinical Perspective. J Oncol 2019;2019:6240505. [PMID: 31885581 DOI: 10.1155/2019/6240505] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
104 Dubois-Camacho K, Diaz-Jimenez D, De la Fuente M, Quera R, Simian D, Martínez M, Landskron G, Olivares-Morales M, Cidlowski JA, Xu X, Gao G, Xie J, Chnaiderman J, Soto-Rifo R, González MJ, Calixto A, Hermoso MA. Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis. Front Immunol 2019;10:2449. [PMID: 31824476 DOI: 10.3389/fimmu.2019.02449] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 5.8] [Reference Citation Analysis]
105 Koh SJ, Kim JW, Kim BG, Lee KL, Kim DW, Kim JS. Matricellular protein periostin promotes colitis-associated colon tumorigenesis in mice. Carcinogenesis 2019;40:102-11. [PMID: 30204842 DOI: 10.1093/carcin/bgy120] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
106 Lin Y, Li B, Yang X, Liu T, Shi T, Deng B, Zhang Y, Jia L, Jiang Z, He R. Non-hematopoietic STAT6 induces epithelial tight junction dysfunction and promotes intestinal inflammation and tumorigenesis. Mucosal Immunol 2019;12:1304-15. [PMID: 31534167 DOI: 10.1038/s41385-019-0204-y] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 6.0] [Reference Citation Analysis]
107 Wong J, Garcia-Carbonell R, Zelic M, Ho SB, Boland BS, Yao SJ, Desai SA, Das S, Planell N, Harris PA, Font-Burgada J, Taniguchi K, Bertin J, Salas A, Pasparakis M, Gough PJ, Kelliher M, Karin M, Guma M. RIPK1 Mediates TNF-Induced Intestinal Crypt Apoptosis During Chronic NF-κB Activation. Cell Mol Gastroenterol Hepatol 2020;9:295-312. [PMID: 31606566 DOI: 10.1016/j.jcmgh.2019.10.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
108 Singh K, Al Khoury A, Kurti Z, Gonczi L, Reinglas J, Verdon C, Kohen R, Bessissow T, Afif W, Wild G, Seidman E, Bitton A, Lakatos PL. High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance. J Crohns Colitis 2019;13:1343-50. [PMID: 30918959 DOI: 10.1093/ecco-jcc/jjz066] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
109 Sammarco G, Shalaby M, Elangovan S, Petti L, Roda G, Restelli S, Arena V, Ungaro F, Fiorino G, Day AJ, D'Alessio S, Vetrano S. Hyaluronan Accelerates Intestinal Mucosal Healing through Interaction with TSG-6. Cells 2019;8:E1074. [PMID: 31547322 DOI: 10.3390/cells8091074] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
110 Andrews C. Ulcerative colitis. InnovAiT 2019;12:501-506. [DOI: 10.1177/1755738019856030] [Reference Citation Analysis]
111 Kim WS, Song HY, Han JM, Byun EB. GLM, a novel luteolin derivative, attenuates inflammatory responses in dendritic cells: Therapeutic potential against ulcerative colitis. Biochem Biophys Res Commun 2019;518:87-93. [PMID: 31402120 DOI: 10.1016/j.bbrc.2019.08.012] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
112 Cohen-Mekelburg S, Schneider Y, Gold S, Ghosh G, Rosenblatt R, Hajifathalian K, Scherl E, Schnoll-Sussman F, Katz P, Steinlauf A. Risk of Early Colorectal Cancers Needs to Be Considered in Inflammatory Bowel Disease Care. Dig Dis Sci 2019;64:2273-9. [PMID: 30815820 DOI: 10.1007/s10620-019-05554-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
113 Zhou H, Ichikawa A, Ikeuchi-Takahashi Y, Hattori Y, Onishi H. Nanogels of Succinylated Glycol Chitosan-Succinyl Prednisolone Conjugate: Preparation, In Vitro Characteristics and Therapeutic Potential. Pharmaceutics 2019;11:E333. [PMID: 31337090 DOI: 10.3390/pharmaceutics11070333] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
114 Hnatyszyn A, Hryhorowicz S, Kaczmarek-Ryś M, Lis E, Słomski R, Scott RJ, Pławski A. Colorectal carcinoma in the course of inflammatory bowel diseases. Hered Cancer Clin Pract 2019;17:18. [PMID: 31338130 DOI: 10.1186/s13053-019-0118-4] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 11.0] [Reference Citation Analysis]
115 Yun CC. Lysophosphatidic Acid and Autotaxin-associated Effects on the Initiation and Progression of Colorectal Cancer. Cancers (Basel) 2019;11:E958. [PMID: 31323936 DOI: 10.3390/cancers11070958] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
116 Yin R, Neyens DM. Online Health Resource Use by Individuals With Inflammatory Bowel Disease: Analysis Using the National Health Interview Survey (Preprint).. [DOI: 10.2196/preprints.15352] [Reference Citation Analysis]
117 Chok KC, Ng CH, Koh RY, Ng KY, Chye SM. The potential therapeutic actions of melatonin in colorectal cancer. Hormone Molecular Biology and Clinical Investigation 2019;39:20190001. [DOI: 10.1515/hmbci-2019-0001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
118 Shafabakhsh R, Reiter RJ, Davoodabadi A, Asemi Z. Melatonin as a potential inhibitor of colorectal cancer: Molecular mechanisms. J Cell Biochem 2019;120:12216-23. [PMID: 31087705 DOI: 10.1002/jcb.28833] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
119 Zhang S, Cao L, Li Z, Qu D. Metabolic reprogramming links chronic intestinal inflammation and the oncogenic transformation in colorectal tumorigenesis. Cancer Letters 2019;450:123-31. [DOI: 10.1016/j.canlet.2019.02.045] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
120 Chen G, Han Y, Feng Y, Wang A, Li X, Deng S, Zhang L, Xiao J, Li Y, Li N. Extract of Ilex rotunda Thunb alleviates experimental colitis-associated cancer via suppressing inflammation-induced miR-31-5p/YAP overexpression. Phytomedicine 2019;62:152941. [PMID: 31100679 DOI: 10.1016/j.phymed.2019.152941] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 4.3] [Reference Citation Analysis]
121 Zhao H, Pan WM, Zhang HH, Song Y, Chen J, Xiang Y, Gu B, Li SZ, Du RL, Zhang XD. Cancer testis antigen 55 deficiency attenuates colitis-associated colorectal cancer by inhibiting NF-κB signaling. Cell Death Dis 2019;10:304. [PMID: 30944312 DOI: 10.1038/s41419-019-1537-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
122 Bruchard M, Ghiringhelli F. Deciphering the Roles of Innate Lymphoid Cells in Cancer. Front Immunol 2019;10:656. [PMID: 31024531 DOI: 10.3389/fimmu.2019.00656] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 9.5] [Reference Citation Analysis]
123 Stellingwerf ME, de Koning MA, Pinkney T, Bemelman WA, D'Haens GR, Buskens CJ. The Risk of Colectomy and Colorectal Cancer After Appendectomy in Patients With Ulcerative Colitis: A Systematic Review and Meta-analysis. J Crohns Colitis 2019;13:309-18. [PMID: 30335149 DOI: 10.1093/ecco-jcc/jjy163] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
124 Wang S, Liu Y, Yuan X, Yao L, Yang S, Ma R. Fecal bacteria from ulcerative colitis patients downregulate Tim-3-mediated inhibitory effects on monocytes in vitro. Microbial Pathogenesis 2019;128:147-52. [DOI: 10.1016/j.micpath.2018.12.043] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
125 Han Y, Zhang L, Li W, Liu X, Xiao J, Chen G, Li N. Natural CAC chemopreventive agents from Ilex rotunda Thunb. J Nat Med 2019;73:456-67. [PMID: 30758715 DOI: 10.1007/s11418-019-01281-z] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
126 Kodama M, Kobayashi D, Iihara K, Abe K, Sahara R, Sassa M, Yamana T, Furukawa S, Yao T, Uchida K, Tamura T, Negi M, Eishi Y. Adenocarcinoma within anorectal fistulae: different clinicopathological characteristics between Crohn's disease-associated type and the usual type. Mod Pathol 2019;32:314-25. [PMID: 30206406 DOI: 10.1038/s41379-018-0105-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
127 Guo Y, Wu R, Gaspar JM, Sargsyan D, Su ZY, Zhang C, Gao L, Cheng D, Li W, Wang C, Yin R, Fang M, Verzi MP, Hart RP, Kong AN. DNA methylome and transcriptome alterations and cancer prevention by curcumin in colitis-accelerated colon cancer in mice. Carcinogenesis 2018;39:669-80. [PMID: 29547900 DOI: 10.1093/carcin/bgy043] [Cited by in Crossref: 65] [Cited by in F6Publishing: 69] [Article Influence: 16.3] [Reference Citation Analysis]
128 Pakiet A, Kobiela J, Stepnowski P, Sledzinski T, Mika A. Changes in lipids composition and metabolism in colorectal cancer: a review. Lipids Health Dis 2019;18:29. [PMID: 30684960 DOI: 10.1186/s12944-019-0977-8] [Cited by in Crossref: 121] [Cited by in F6Publishing: 129] [Article Influence: 30.3] [Reference Citation Analysis]
129 De Almeida CV, de Camargo MR, Russo E, Amedei A. Role of diet and gut microbiota on colorectal cancer immunomodulation. World J Gastroenterol 2019; 25(2): 151-162 [PMID: 30670906 DOI: 10.3748/wjg.v25.i2.151] [Cited by in CrossRef: 82] [Cited by in F6Publishing: 83] [Article Influence: 20.5] [Reference Citation Analysis]
130 Lin Y, Li B, Yang X, Chen Y, Liu T, Shi T, Deng B, Zhang Y, Jia L, Jiang Z, He R. STAT6 Induces MLCK1-Dependent Epithelial Tight Junction Dysfunction and Promotes Intestinal Inflammation and Tumorigenesis. SSRN Journal. [DOI: 10.2139/ssrn.3316798] [Reference Citation Analysis]
131 Adithya G, Madaan V, Gupta R, Jindal S, Govil D. Malignant perforation of sigmoid colon in long-standing ulcerative colitis. Apollo Med 2019;16:187. [DOI: 10.4103/am.am_33_19] [Reference Citation Analysis]
132 Wu XR, Zheng XB, Huang Y, Cao Q, Zhang HJ, Miao YL, Zou KF, Chen M, Zhang FM, Mei Q, Gonzalo D, Allende D, Hu PJ, Shen B, Liu XL, Lan P. Risk factors for colorectal neoplasia in patients with underlying inflammatory bowel disease: a multicenter study. Gastroenterol Rep (Oxf) 2019;7:67-73. [PMID: 30792868 DOI: 10.1093/gastro/goy039] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
133 Binabaj MM, Asgharzadeh F, Avan A, Rahmani F, Soleimani A, Parizadeh MR, Ferns GA, Ryzhikov M, Khazaei M, Hassanian SM. EW‐7197 prevents ulcerative colitis‐associated fibrosis and inflammation. J Cell Physiol 2019;234:11654-61. [DOI: 10.1002/jcp.27823] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
134 Hall MJ, Morris AM, Sun W. Precision Medicine Versus Population Medicine in Colon Cancer: From Prospects of Prevention, Adjuvant Chemotherapy, and Surveillance. Am Soc Clin Oncol Educ Book 2018;38:220-30. [PMID: 30231337 DOI: 10.1200/EDBK_200961] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
135 Lee YK, Mehrabian P, Boyajian S, Wu WL, Selicha J, Vonderfecht S, Mazmanian SK. The Protective Role of Bacteroides fragilis in a Murine Model of Colitis-Associated Colorectal Cancer. mSphere 2018;3:e00587-18. [PMID: 30429227 DOI: 10.1128/mSphere.00587-18] [Cited by in Crossref: 45] [Cited by in F6Publishing: 55] [Article Influence: 9.0] [Reference Citation Analysis]
136 Hoving JC. Targeting IL-13 as a Host-Directed Therapy Against Ulcerative Colitis. Front Cell Infect Microbiol 2018;8:395. [PMID: 30460209 DOI: 10.3389/fcimb.2018.00395] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
137 Gonzalez H, Hagerling C, Werb Z. Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes Dev. 2018;32:1267-1284. [PMID: 30275043 DOI: 10.1101/gad.314617.118] [Cited by in Crossref: 765] [Cited by in F6Publishing: 829] [Article Influence: 153.0] [Reference Citation Analysis]
138 Sochal M, Mosińska P, Fichna J. Diagnostic value of chemerin in lower gastrointestinal diseases—a review. Peptides 2018;108:19-24. [DOI: 10.1016/j.peptides.2018.08.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
139 Song J, Chen Z, Geng T, Wang M, Yi S, Liu K, Zhou W, Gao J, Song W, Tang H. Deleting MyD88 signaling in myeloid cells promotes development of adenocarcinomas of the colon. Cancer Lett 2018;433:65-75. [PMID: 29960049 DOI: 10.1016/j.canlet.2018.06.036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
140 Choo J, Heo G, Kim SJ, Lee Y, Ishigami A, Maruyama N, Chung HY, Im E. Senescence marker protein 30 protects intestinal epithelial cells against inflammation-induced cell death by enhancing Nrf2 activity. Biochim Biophys Acta Mol Basis Dis 2018;1864:3668-78. [PMID: 30266650 DOI: 10.1016/j.bbadis.2018.09.031] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
141 Sharp SP, Malizia RA, Walrath T, D'Souza SS, Booth CJ, Kartchner BJ, Lee EC, Stain SC, O'Connor W Jr. DNA damage response genes mark the early transition from colitis to neoplasia in colitis-associated colon cancer. Gene 2018;677:299-307. [PMID: 30121380 DOI: 10.1016/j.gene.2018.08.016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
142 Kim SH, Kim JW, Lee KL, Lee S, Koh SJ, Jeong JB, Kim BG. Hepatitis B Virus Infection Is Independently Associated With Advanced Colorectal Adenoma. Am J Med Sci 2018;356:141-6. [PMID: 30219156 DOI: 10.1016/j.amjms.2018.04.016] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
143 Lian L, Feng Y, Li YW, Bei B, Tang YT, Wang H, Feng QM, Chen G. Two new triterpenes from the roots of Pfaffia glomerata. J Asian Nat Prod Res 2019;21:442-8. [PMID: 29607660 DOI: 10.1080/10286020.2018.1446949] [Reference Citation Analysis]
144 Stidham RW, Higgins PDR. Colorectal Cancer in Inflammatory Bowel Disease. Clin Colon Rectal Surg. 2018;31:168-178. [PMID: 29720903 DOI: 10.1055/s-0037-1602237] [Cited by in Crossref: 125] [Cited by in F6Publishing: 106] [Article Influence: 25.0] [Reference Citation Analysis]
145 Walter L, Pujada A, Bhatnagar N, Bialkowska AB, Yang VW, Laroui H, Garg P. Epithelial derived-matrix metalloproteinase (MMP9) exhibits a novel defensive role of tumor suppressor in colitis associated cancer by activating MMP9-Notch1-ARF-p53 axis. Oncotarget 2017;8:364-78. [PMID: 27861153 DOI: 10.18632/oncotarget.13406] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
146 Sun T, Liu S, Zhou Y, Yao Z, Zhang D, Cao S, Wei Z, Tan B, Li Y, Lian Z, Wang S. Evolutionary biologic changes of gut microbiota in an 'adenoma-carcinoma sequence' mouse colorectal cancer model induced by 1, 2-Dimethylhydrazine. Oncotarget 2017;8:444-57. [PMID: 27880935 DOI: 10.18632/oncotarget.13443] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 6.6] [Reference Citation Analysis]
147 Chung KS, Cheon SY, Roh SS, Lee M, An HJ. Chemopreventive Effect of Aster glehni on Inflammation-Induced Colorectal Carcinogenesis in Mice. Nutrients 2018;10:E202. [PMID: 29439531 DOI: 10.3390/nu10020202] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
148 Hernandez P, Gronke K, Diefenbach A. A catch-22: Interleukin-22 and cancer. Eur J Immunol 2018;48:15-31. [DOI: 10.1002/eji.201747183] [Cited by in Crossref: 63] [Cited by in F6Publishing: 68] [Article Influence: 12.6] [Reference Citation Analysis]
149 Fung KY, Putoczki T. In Vivo Models of Inflammatory Bowel Disease and Colitis-Associated Cancer. Methods Mol Biol 2018;1725:3-13. [PMID: 29322404 DOI: 10.1007/978-1-4939-7568-6_1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
150 Zhang X, Wei L, Wang J, Qin Z, Lu Y, Zheng X, Peng Q, Ye Q, Ai F, Liu P, Wang S, Li G, Shen S, Ma J. Suppression Colitis and Colitis-Associated Colon Cancer by Anti-S100a9 Antibody in Mice. Front Immunol. 2017;8:1774. [PMID: 29326691 DOI: 10.3389/fimmu.2017.01774] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 8.5] [Reference Citation Analysis]
151 Wang YN, Li J, Zheng WY, Wu D, Yang H, Li Y, Lv H, Tan B, Shu HJ, Sun XY, Qian JM, Wu B, Li JN. Clinical characteristics of ulcerative colitis-related colorectal cancer in Chinese patients. J Dig Dis 2017;18:684-90. [PMID: 29119678 DOI: 10.1111/1751-2980.12558] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
152 Bisson WH, Amedei A, Memeo L, Forte S, Felsher DW. Tumor-Promoting/Associated Inflammation and the Microenvironment: A State of the Science and New Horizons. Translational Toxicology and Therapeutics: Windows of Developmental Susceptibility in Reproduction and Cancer 2017. [DOI: 10.1002/9781119023647.ch14] [Reference Citation Analysis]
153 Fingleton B. Matrix metalloproteinases as regulators of inflammatory processes. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2017;1864:2036-42. [DOI: 10.1016/j.bbamcr.2017.05.010] [Cited by in Crossref: 118] [Cited by in F6Publishing: 125] [Article Influence: 19.7] [Reference Citation Analysis]
154 Chen J, Pitmon E, Wang K. Microbiome, inflammation and colorectal cancer. Semin Immunol. 2017;32:43-53. [PMID: 28982615 DOI: 10.1016/j.smim.2017.09.006] [Cited by in Crossref: 140] [Cited by in F6Publishing: 131] [Article Influence: 23.3] [Reference Citation Analysis]
155 Chotivitayatarakorn P, Vilaichone RK. Colorectal Cancer and Precancerous Lesions Associated with Ulcerative Colitis in Thailand. Asian Pac J Cancer Prev 2017;18:2123-6. [PMID: 28843232 DOI: 10.22034/APJCP.2017.18.8.2123] [Reference Citation Analysis]
156 Rademakers G, Vaes N, Schonkeren S, Koch A, Sharkey KA, Melotte V. The role of enteric neurons in the development and progression of colorectal cancer. Biochim Biophys Acta Rev Cancer 2017;1868:420-34. [PMID: 28847715 DOI: 10.1016/j.bbcan.2017.08.003] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 2.7] [Reference Citation Analysis]
157 Geng R, Tan X, Wu J, Pan Z, Yi M, Shi W, Liu R, Yao C, Wang G, Lin J, Qiu L, Huang W, Chen S. RNF183 promotes proliferation and metastasis of colorectal cancer cells via activation of NF-κB-IL-8 axis. Cell Death Dis 2017;8:e2994. [PMID: 28796265 DOI: 10.1038/cddis.2017.400] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 6.8] [Reference Citation Analysis]
158 周威. 布拉氏酵母菌散对活动期溃疡性结肠炎钙卫蛋白及炎性因子的影响. 世界华人消化杂志 2017; 25(22): 2065-2070 [DOI: 10.11569/wcjd.v25.i22.2065] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
159 Geng R, Tan X, Zuo Z, Wu J, Pan Z, Shi W, Liu R, Yao C, Wang G, Lin J, Qiu L, Huang W, Chen S. Synthetic lethal short hairpin RNA screening reveals that ring finger protein 183 confers resistance to trametinib in colorectal cancer cells. Chin J Cancer 2017;36:63. [PMID: 28756770 DOI: 10.1186/s40880-017-0228-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
160 Gemoll T, Kollbeck SL, Karstens KF, Hò GG, Hartwig S, Strohkamp S, Schillo K, Thorns C, Oberländer M, Kalies K, Lehr S, Habermann JK. EB1 protein alteration characterizes sporadic but not ulcerative colitis associated colorectal cancer. Oncotarget 2017;8:54939-50. [PMID: 28903393 DOI: 10.18632/oncotarget.18978] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
161 Kazuhiro Kobayashi, Hiroyuki Tomita, Masahito Shimizu, Takuji Tanaka, Natsuko Suzui, Tatsuhiko Miyazaki, Akira Hara. p53 Expression as a Diagnostic Biomarker in Ulcerative Colitis-Associated Cancer. Int J Mol Sci 2017;18:1284. [PMID: 28621756 DOI: 10.3390/ijms18061284] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
162 Liu C, Liu ED, Meng YX, Dong XM, Bi YL, Wu HW, Jin YC, Zhao K, Li JJ, Yu M, Zhan YQ, Chen H, Ge CH, Yang XM, Li CY. Keratin 8 reduces colonic permeability and maintains gut microbiota homeostasis, protecting against colitis and colitis-associated tumorigenesis. Oncotarget 2017;8:96774-90. [PMID: 29228570 DOI: 10.18632/oncotarget.18241] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
163 Mao H, Pan F, Wu Z, Wang Z, Zhou Y, Zhang P, Gou M, Dai G. Colorectal tumors are enriched with regulatory plasmablasts with capacity in suppressing T cell inflammation. Int Immunopharmacol 2017;49:95-101. [PMID: 28558303 DOI: 10.1016/j.intimp.2017.05.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
164 Ohnishi T, Hashizume C, Taniguchi M, Furumoto H, Han J, Gao R, Kinami S, Kosaka T, Okazaki T. Sphingomyelin synthase 2 deficiency inhibits the induction of murine colitis-associated colon cancer. FASEB J 2017;31:3816-30. [PMID: 28522594 DOI: 10.1096/fj.201601225RR] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 5.5] [Reference Citation Analysis]
165 Han YD, Al Bandar MH, Dulskas A, Cho MS, Hur H, Min BS, Lee KY, Kim NK. Prognosis of ulcerative colitis colorectal cancer vs. sporadic colorectal cancer: propensity score matching analysis. BMC Surg 2017;17:28. [PMID: 28327112 DOI: 10.1186/s12893-017-0224-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
166 Ma X, Meng Z, Jin L, Xiao Z, Wang X, Tsark WM, Ding L, Gu Y, Zhang J, Kim B, He M, Gan X, Shively JE, Yu H, Xu R, Huang W. CAMK2γ in intestinal epithelial cells modulates colitis-associated colorectal carcinogenesis via enhancing STAT3 activation. Oncogene 2017;36:4060-71. [PMID: 28319059 DOI: 10.1038/onc.2017.16] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
167 Burr NE, Hull MA, Subramanian V. Folic Acid Supplementation May Reduce Colorectal Cancer Risk in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. J Clin Gastroenterol 2017;51:247-53. [PMID: 26905603 DOI: 10.1097/MCG.0000000000000498] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 8.2] [Reference Citation Analysis]
168 Kuznietsova HM, Yena MS, Kotlyar IP, Ogloblya OV, Rybalchenko VK. Anti-Inflammatory Effects of Protein Kinase Inhibitor Pyrrol Derivate. ScientificWorldJournal 2016;2016:2145753. [PMID: 28101521 DOI: 10.1155/2016/2145753] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
169 Zhang Y, Wang J, Wang W, Tian J, Yin K, Tang X, Ma J, Xu H, Wang S. IL-17A produced by peritoneal macrophages promote the accumulation and function of granulocytic myeloid-derived suppressor cells in the development of colitis-associated cancer. Tumour Biol 2016. [PMID: 27909978 DOI: 10.1007/s13277-016-5414-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
170 Yoshino T, Nakase H, Takagi T, Bamba S, Okuyama Y, Kawamura T, Oki T, Obata H, Kawanami C, Katsushima S, Kusaka T, Tsujikawa T, Naito Y, Andoh A, Kogawa T. Risk factors for developing colorectal cancer in Japanese patients with ulcerative colitis: a retrospective observational study-CAPITAL (Cohort and Practice for IBD total management in Kyoto-Shiga Links) study I. BMJ Open Gastroenterol 2016;3:e000122. [PMID: 27933204 DOI: 10.1136/bmjgast-2016-000122] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
171 Han J, Xi Q, Meng Q, Liu J, Zhang Y, Han Y, Zhuang Q, Jiang Y, Ding Q, Wu G. Interleukin-6 promotes tumor progression in colitis-associated colorectal cancer through HIF-1α regulation. Oncol Lett 2016;12:4665-70. [PMID: 28105173 DOI: 10.3892/ol.2016.5227] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
172 Zheng H, Lu Z, Wang R, Chen N, Zheng P. Establishing the colitis-associated cancer progression mouse models. Int J Immunopathol Pharmacol 2016;29:759-63. [PMID: 27694612 DOI: 10.1177/0394632016670919] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
173 Baidoo L, Hanauer SB. What Is the Best Approach to Avoid Colorectal Cancer Risk in Inflammatory Bowel Disease? Curr Colorectal Cancer Rep 2016;12:345-51. [DOI: 10.1007/s11888-016-0339-0] [Reference Citation Analysis]
174 López-Posadas R, Neurath MF, Atreya I. Molecular pathways driving disease-specific alterations of intestinal epithelial cells. Cell Mol Life Sci 2017;74:803-26. [PMID: 27624395 DOI: 10.1007/s00018-016-2363-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
175 Huppertz-Hauss G, Aas E, Lie Høivik M, Langholz E, Odes S, Småstuen M, Stockbrugger R, Hoff G, Moum B, Bernklev T. Comparison of the Multiattribute Utility Instruments EQ-5D and SF-6D in a Europe-Wide Population-Based Cohort of Patients with Inflammatory Bowel Disease 10 Years after Diagnosis. Gastroenterol Res Pract 2016;2016:5023973. [PMID: 27630711 DOI: 10.1155/2016/5023973] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
176 Pellino G, Marcellinaro R, Sciaudone G, Reginelli A, Esposito P, Riegler G, Canonico S, Villanacci V, Selvaggi F. Large bowel cancer in the setting of inflammatory bowel disease: Features and management with a focus on rectal cancer. Eur Surg 2016;48:191-202. [DOI: 10.1007/s10353-016-0434-0] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
177 Kim H, Banerjee N, Ivanov I, Pfent CM, Prudhomme KR, Bisson WH, Dashwood RH, Talcott ST, Mertens-Talcott SU. Comparison of anti-inflammatory mechanisms of mango (Mangifera Indica L.) and pomegranate (Punica Granatum L.) in a preclinical model of colitis. Mol Nutr Food Res 2016;60:1912-23. [PMID: 27028006 DOI: 10.1002/mnfr.201501008] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 7.6] [Reference Citation Analysis]
178 Kim JS, Kim YG, Park EJ, Kim B, Lee HK, Hong JT, Kim Y, Han SB. Cell-based Immunotherapy for Colorectal Cancer with Cytokine-induced Killer Cells. Immune Netw 2016;16:99-108. [PMID: 27162526 DOI: 10.4110/in.2016.16.2.99] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
179 Zhang Y, Davis C, Shah S, Hughes D, Ryan JC, Altomare D, Peña MM. IL-33 promotes growth and liver metastasis of colorectal cancer in mice by remodeling the tumor microenvironment and inducing angiogenesis. Mol Carcinog 2017;56:272-87. [PMID: 27120577 DOI: 10.1002/mc.22491] [Cited by in Crossref: 82] [Cited by in F6Publishing: 89] [Article Influence: 11.7] [Reference Citation Analysis]
180 Kinugasa T, Akagi Y. Status of colitis-associated cancer in ulcerative colitis. World J Gastrointest Oncol 2016; 8(4): 351-357 [PMID: 27096030 DOI: 10.4251/wjgo.v8.i4.351] [Cited by in CrossRef: 41] [Cited by in F6Publishing: 46] [Article Influence: 5.9] [Reference Citation Analysis]
181 Kim H, Banerjee N, Barnes RC, Pfent CM, Talcott ST, Dashwood RH, Mertens-Talcott SU. Mango polyphenolics reduce inflammation in intestinal colitis-involvement of the miR-126/PI3K/AKT/mTOR axis in vitro and in vivo. Mol Carcinog 2017;56:197-207. [PMID: 27061150 DOI: 10.1002/mc.22484] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 9.1] [Reference Citation Analysis]
182 Rasic I, Radovic S, Aksamija G. Relationship Between Chronic Inflammation and the Stage and Histopathological Size of Colorectal Carcinoma. Med Arch 2016;70:104-7. [PMID: 27147782 DOI: 10.5455/medarh.2016.70.104-107] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
183 Hagerling C, Werb Z. Neutrophils: Critical components in experimental animal models of cancer. Semin Immunol 2016;28:197-204. [PMID: 26976824 DOI: 10.1016/j.smim.2016.02.003] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
184 Zou F, Mao R, Yang L, Lin S, Lei K, Zheng Y, Ding Y, Zhang P, Cai G, Liang X, Liu J. Targeted deletion of miR-139-5p activates MAPK, NF-κB and STAT3 signaling and promotes intestinal inflammation and colorectal cancer. FEBS J 2016;283:1438-52. [PMID: 26859226 DOI: 10.1111/febs.13678] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 7.3] [Reference Citation Analysis]
185 Lin L, Sun Y, Wang D, Zheng S, Zhang J, Zheng C. Celastrol Ameliorates Ulcerative Colitis-Related Colorectal Cancer in Mice via Suppressing Inflammatory Responses and Epithelial-Mesenchymal Transition. Front Pharmacol. 2015;6:320. [PMID: 26793111 DOI: 10.3389/fphar.2015.00320] [Cited by in Crossref: 21] [Cited by in F6Publishing: 42] [Article Influence: 3.0] [Reference Citation Analysis]
186 Parang B, Barrett CW, Williams CS. AOM/DSS Model of Colitis-Associated Cancer. Methods Mol Biol 2016;1422:297-307. [PMID: 27246042 DOI: 10.1007/978-1-4939-3603-8_26] [Cited by in Crossref: 90] [Cited by in F6Publishing: 96] [Article Influence: 12.9] [Reference Citation Analysis]
187 Okita Y, Araki T, Tanaka K, Toiyama Y, Uchida K, Kusunoki M. Cancer Surveillance of Patients with Long-Standing Inflammatory Bowel Disease. Colitis-Associated Cancer 2016. [DOI: 10.1007/978-4-431-55522-3_4] [Reference Citation Analysis]
188 Wang D, DuBois RN. Immunosuppression associated with chronic inflammation in the tumor microenvironment. Carcinogenesis 2015;36:1085-93. [PMID: 26354776 DOI: 10.1093/carcin/bgv123] [Cited by in Crossref: 200] [Cited by in F6Publishing: 211] [Article Influence: 25.0] [Reference Citation Analysis]
189 Tang Y, Chen Y, Wang X, Song G, Li Y, Shi L. Combinatorial Intervention with Mesenchymal Stem Cells and Granulocyte Colony-Stimulating Factor in a Rat Model of Ulcerative Colitis. Dig Dis Sci 2015;60:1948-57. [PMID: 25894931 DOI: 10.1007/s10620-015-3655-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
190 Wang YR, Cangemi JR, Loftus EV Jr, Picco MF. Use of surveillance colonoscopy in medicare patients with inflammatory bowel disease prior to colorectal cancer diagnosis. Digestion 2014;90:58-62. [PMID: 25196002 DOI: 10.1159/000363053] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
191 Manzat-Saplacan RM, Mircea PA, Balacescu L, Chira RI, Berindan-Neagoe I, Balacescu O. Can we change our microbiome to prevent colorectal cancer development? Acta Oncol 2015;54:1085-95. [PMID: 26073561 DOI: 10.3109/0284186X.2015.1054949] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
192 Zhang QY, Wang L, Song ZY, Qu XJ. Knockdown of type I insulin-like growth factor receptor inhibits human colorectal cancer cell growth and downstream PI3K/Akt, WNT/β-catenin signal pathways. Biomed Pharmacother 2015;73:12-8. [PMID: 26211576 DOI: 10.1016/j.biopha.2015.05.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
193 Wang K, Karin M. Tumor-Elicited Inflammation and Colorectal Cancer. Adv Cancer Res 2015;128:173-96. [PMID: 26216633 DOI: 10.1016/bs.acr.2015.04.014] [Cited by in Crossref: 106] [Cited by in F6Publishing: 111] [Article Influence: 13.3] [Reference Citation Analysis]
194 Yunusi K, Zhang J, Zhong L, Mosha G, Nuermaimaiti A, Abudula M, Upur H. Uygur medicine Xipayi Kui Jie'an affects gene expression profiles in intestinal tissue lesions in a rat model of ulcerative colitis. BMC Complement Altern Med 2015;15:152. [PMID: 25997744 DOI: 10.1186/s12906-015-0672-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
195 Martin M, Kesselring RK, Saidou B, Brunner SM, Schiechl G, Mouris VF, Wege AK, Rümmele P, Schlitt HJ, Geissler EK. RORγt(+) hematopoietic cells are necessary for tumor cell proliferation during colitis-associated tumorigenesis in mice. Eur J Immunol. 2015;45:1667-1679. [PMID: 25820779 DOI: 10.1002/eji.201444915] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.8] [Reference Citation Analysis]
196 Zhang L, Fan XM. The pathological role of microRNAs and inflammation in colon carcinogenesis. Clin Res Hepatol Gastroenterol 2015;39:174-9. [PMID: 25154001 DOI: 10.1016/j.clinre.2014.06.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
197 Sada H, Shimomura M, Hinoi T, Egi H, Kawaguchi K, Yano T, Niitsu H, Saitou Y, Sawada H, Miguchi M, Adachi T, Ohdan H. Avoiding restorative proctocolectomy for colorectal cancer in patients with ulcerative colitis based on preoperative diagnosis involving p53 immunostaining: report of a case. World J Surg Oncol 2015;13:123. [PMID: 25888857 DOI: 10.1186/s12957-015-0540-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
198 Hanley MP, Rosenberg DW. One-Carbon Metabolism and Colorectal Cancer: Potential Mechanisms of Chemoprevention. Curr Pharmacol Rep 2015;1:197-205. [PMID: 26207201 DOI: 10.1007/s40495-015-0028-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
199 Ernst M, Preaudet A, Putoczki T. Non-invasive assessment of the efficacy of new therapeutics for intestinal pathologies using serial endoscopic imaging of live mice. J Vis Exp 2015. [PMID: 25867916 DOI: 10.3791/52383] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
200 Wu SC, Chen WT, Muo CH, Ke TW, Fang CW, Sung FC. Association between appendectomy and subsequent colorectal cancer development: an Asian population study. PLoS One. 2015;10:e0118411. [PMID: 25710790 DOI: 10.1371/journal.pone.0118411] [Cited by in Crossref: 41] [Cited by in F6Publishing: 44] [Article Influence: 5.1] [Reference Citation Analysis]
201 McDonald BF, Quinn AM, Devers T, Cullen A, Coulter IS, Marison IW, Loughran ST. In-vitro characterisation of a novel celecoxib microbead formulation for the treatment and prevention of colorectal cancer. J Pharm Pharmacol 2015;67:685-95. [PMID: 25650335 DOI: 10.1111/jphp.12372] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
202 Biddlestone J, Bandarra D, Rocha S. The role of hypoxia in inflammatory disease (review). Int J Mol Med. 2015;35:859-869. [PMID: 25625467 DOI: 10.3892/ijmm.2015.2079] [Cited by in Crossref: 112] [Cited by in F6Publishing: 114] [Article Influence: 14.0] [Reference Citation Analysis]
203 Wang SX, Jin BF, Cui LH. Gankyrin regulates colitis-associated cancer via NF-κB signaling pathway. Shijie Huaren Xiaohua Zazhi 2015; 23(2): 189-195 [DOI: 10.11569/wcjd.v23.i2.189] [Reference Citation Analysis]
204 Theodoulakis C, Apidianakis Y. Parallels Between Mammals and Flies in Inflammatory Bowel Disease. Life Extension 2015. [DOI: 10.1007/978-3-319-18326-8_7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
205 Schmelz EM, Zhou H, Roberts PC. Dietary Sphingolipids in Colon Cancer Prevention. Bioactive Sphingolipids in Cancer Biology and Therapy 2015. [DOI: 10.1007/978-3-319-20750-6_8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
206 Yan ZH, Cui LH, Wang XH, Li C, He X. Comparative study of mutations in SNP loci of K-RAS, hMLH1 and hMSH2 genes in neoplastic intestinal polyps and colorectal cancer. World J Gastroenterol 2014; 20(48): 18338-18345 [PMID: 25561800 DOI: 10.3748/wjg.v20.i48.18338] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
207 Herszényi L, Barabás L, Miheller P, Tulassay Z. Colorectal cancer in patients with inflammatory bowel disease: the true impact of the risk. Dig Dis 2015;33:52-7. [PMID: 25531497 DOI: 10.1159/000368447] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 5.7] [Reference Citation Analysis]
208 Waldner MJ, Neurath MF. Mechanisms of Immune Signaling in Colitis-Associated Cancer. Cell Mol Gastroenterol Hepatol 2015;1:6-16. [PMID: 28247866 DOI: 10.1016/j.jcmgh.2014.11.006] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 5.9] [Reference Citation Analysis]
209 Bosso MC, Marchesa PE, Ricchiuti A, Giacardi A, Cocchis D, Campi M, Palisi M, Salizzoni M. Proctocolectomy for ulcerative colitis after liver transplantation for primary sclerosing cholangitis. Transplant Proc. 2009;41:1390-1392. [PMID: 19460568 DOI: 10.1016/j.transproceed.2009.03.027] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
210 Wang W, Li X, Zheng D, Zhang D, Peng X, Zhang X, Ai F, Wang X, Ma J, Xiong W, Li G, Zhou Y, Shen S. Dynamic changes and functions of macrophages and M1/M2 subpopulations during ulcerative colitis-associated carcinogenesis in an AOM/DSS mouse model. Mol Med Rep 2015;11:2397-406. [PMID: 25434400 DOI: 10.3892/mmr.2014.3018] [Cited by in Crossref: 32] [Cited by in F6Publishing: 35] [Article Influence: 3.6] [Reference Citation Analysis]
211 Hagerling C, Casbon AJ, Werb Z. Balancing the innate immune system in tumor development. Trends Cell Biol. 2015;25:214-220. [PMID: 25444276 DOI: 10.1016/j.tcb.2014.11.001] [Cited by in Crossref: 82] [Cited by in F6Publishing: 70] [Article Influence: 9.1] [Reference Citation Analysis]
212 Chung KS, Choi HE, Shin JS, Cho EJ, Cho YW, Choi JH, Baek NI, Lee KT. Chemopreventive effects of standardized ethanol extract from the aerial parts of Artemisia princeps Pampanini cv. Sajabal via NF-κB inactivation on colitis-associated colon tumorigenesis in mice. Food Chem Toxicol 2015;75:14-23. [PMID: 25449198 DOI: 10.1016/j.fct.2014.11.007] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
213 León-Cabrera S, Callejas BE, Ledesma-Soto Y, Coronel J, Pérez-Plasencia C, Gutiérrez-Cirlos EB, Ávila-Moreno F, Rodríguez-Sosa M, Hernández-Pando R, Marquina-Castillo B, Chirino YI, Terrazas LI. Extraintestinal helminth infection reduces the development of colitis-associated tumorigenesis. Int J Biol Sci 2014;10:948-56. [PMID: 25210492 DOI: 10.7150/ijbs.9033] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
214 Kim ER, Chang DK. Colorectal cancer in inflammatory bowel disease: The risk, pathogenesis, prevention and diagnosis. World J Gastroenterol 2014; 20(29): 9872-9881 [PMID: 25110418 DOI: 10.3748/wjg.v20.i29.9872] [Cited by in CrossRef: 264] [Cited by in F6Publishing: 272] [Article Influence: 29.3] [Reference Citation Analysis]
215 Han J, Wang J, Wang JH. Effects of jianpi herbal suppository on hemorheology and CD62p in patients with ulcerative colitis. J Tradit Chin Med. 2014;34:155-158. [PMID: 24783925 DOI: 10.1016/s0254-6272(14)60070-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
216 Cui G, Yang H, Zhao J, Yuan A, Florholmen J. Elevated proinflammatory cytokine IL-17A in the adjacent tissues along the adenoma-carcinoma sequence. Pathol Oncol Res 2015;21:139-46. [PMID: 24859972 DOI: 10.1007/s12253-014-9799-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
217 Hofmanová J, Straková N, Vaculová AH, Tylichová Z, Safaříková B, Skender B, Kozubík A. Interaction of dietary fatty acids with tumour necrosis factor family cytokines during colon inflammation and cancer. Mediators Inflamm 2014;2014:848632. [PMID: 24876678 DOI: 10.1155/2014/848632] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 4.4] [Reference Citation Analysis]
218 Omrane I, Marrakchi R, Baroudi O, Mezlini A, Ayari H, Medimegh I, Stambouli N, Kourda N, Bouzaienne H, Uhrhammer N, Bougatef K, Bignon YJ, Benammar-Elgaaied A. Significant association between interleukin-17A polymorphism and colorectal cancer. Tumour Biol 2014;35:6627-32. [PMID: 24699997 DOI: 10.1007/s13277-014-1890-4] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 3.8] [Reference Citation Analysis]
219 Irrazábal T, Belcheva A, Girardin S, Martin A, Philpott D. The Multifaceted Role of the Intestinal Microbiota in Colon Cancer. Molecular Cell 2014;54:309-20. [DOI: 10.1016/j.molcel.2014.03.039] [Cited by in Crossref: 218] [Cited by in F6Publishing: 187] [Article Influence: 24.2] [Reference Citation Analysis]
220 Khan S, Cameron S, Blaschke M, Moriconi F, Naz N, Amanzada A, Ramadori G, Malik IA. Differential gene expression of chemokines in KRAS and BRAF mutated colorectal cell lines: Role of cytokines. World J Gastroenterol 2014; 20(11): 2979-2994 [PMID: 24659889 DOI: 10.3748/wjg.v20.i11.2979] [Cited by in CrossRef: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
221 Zhang C, Monk JM, Lu JT, Zarepoor L, Wu W, Liu R, Pauls KP, Wood GA, Robinson L, Tsao R. Cooked navy and black bean diets improve biomarkers of colon health and reduce inflammation during colitis. Br J Nutr. 2014;111:1549-1563. [PMID: 24521520 DOI: 10.1017/s0007114513004352] [Cited by in Crossref: 66] [Cited by in F6Publishing: 66] [Article Influence: 7.3] [Reference Citation Analysis]
222 Candela M, Turroni S, Biagi E, Carbonero F, Rampelli S, Fiorentini C, Brigidi P. Inflammation and colorectal cancer, when microbiota-host mutualism breaks. World J Gastroenterol 2014; 20(4): 908-922 [PMID: 24574765 DOI: 10.3748/wjg.v20.i4.908] [Cited by in CrossRef: 150] [Cited by in F6Publishing: 152] [Article Influence: 16.7] [Reference Citation Analysis]
223 Omrane I, Baroudi O, Bougatef K, Mezlini A, Abidi A, Medimegh I, Stambouli N, Ayari H, Kourda N, Uhrhammer N, Bignon YJ, Benammar Elgaaied A, Marrakchi R. Significant association between IL23R and IL17F polymorphisms and clinical features of colorectal cancer. Immunol Lett 2014;158:189-94. [PMID: 24440568 DOI: 10.1016/j.imlet.2014.01.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 2.9] [Reference Citation Analysis]
224 Janakiram NB, Rao CV. The role of inflammation in colon cancer. Adv Exp Med Biol 2014;816:25-52. [PMID: 24818718 DOI: 10.1007/978-3-0348-0837-8_2] [Cited by in Crossref: 111] [Cited by in F6Publishing: 122] [Article Influence: 12.3] [Reference Citation Analysis]
225 Li Q, Wang Q, Xu X, Ren S, Wang L. Association between IL-4 -589C>T polymorphism and colorectal cancer risk. Tumour Biol 2014;35:2675-9. [PMID: 24218339 DOI: 10.1007/s13277-013-1352-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
226 Katoh H, Wang D, Daikoku T, Sun H, Dey SK, Dubois RN. CXCR2-expressing myeloid-derived suppressor cells are essential to promote colitis-associated tumorigenesis. Cancer Cell 2013;24:631-44. [PMID: 24229710 DOI: 10.1016/j.ccr.2013.10.009] [Cited by in Crossref: 325] [Cited by in F6Publishing: 291] [Article Influence: 32.5] [Reference Citation Analysis]
227 Senanayake SM, Fernandopulle AN, Niriella MA, Wijesinghe NT, Ranaweera A, Mufeena MN, Pathmeswaran A, Nawarathne NM, de Silva AP, de Silva HJ. The long-term outcomes of a cohort of Sri Lankan patients with ulcerative colitis: a retrospective study at two national referral centers and review of literature. Clin Exp Gastroenterol. 2013;6:195-200. [PMID: 24068873 DOI: 10.2147/ceg.s49202] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
228 Theiss AL. Sphingosine-1-phosphate: Driver of NFκB and STAT3 persistent activation in chronic intestinal inflammation and colitis-associated cancer. JAKSTAT 2013;2:e24150. [PMID: 24069553 DOI: 10.4161/jkst.24150] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
229 Gómez-García M, Cabello-Tapia MJ, Sánchez-Capilla AD, Teresa-Galván JD, Redondo-Cerezo E. Thiopurines related malignancies in inflammatory bowel disease: Local experience in Granada, Spain. World J Gastroenterol 2013; 19(30): 4877-4886 [PMID: 23946592 DOI: 10.3748/wjg.v19.i30.4877] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
230 Moriasi C, Subramaniam D, Awasthi S, Ramalingam S, Anant S. Prevention of colitis-associated cancer: natural compounds that target the IL-6 soluble receptor. Anticancer Agents Med Chem 2012;12:1221-38. [PMID: 22583410 DOI: 10.2174/187152012803833080] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
231 Juasook A, Aukkanimart R, Boonmars T, Sudsarn P, Wonkchalee N, Laummaunwai P, Sriraj P. Tumor-Related Gene Changes in Immunosuppressive Syrian Hamster Cholangiocarcinoma. Pathol Oncol Res 2013;19:785-94. [DOI: 10.1007/s12253-013-9645-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
232 Matsumoto S, Miyatani H, Yoshida Y. Ulcerative colitis: comparison between elderly and young adult patients and between elderly patients with late-onset and long-standing disease. Dig Dis Sci 2013;58:1306-12. [PMID: 23306844 DOI: 10.1007/s10620-012-2517-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
233 Wang W, Li X, Zheng D, Zhang D, Huang S, Zhang X, Ai F, Wang X, Ma J, Xiong W, Zhou Y, Li G, Shen S. Dynamic changes of peritoneal macrophages and subpopulations during ulcerative colitis to metastasis of colorectal carcinoma in a mouse model. Inflamm Res 2013;62:669-80. [DOI: 10.1007/s00011-013-0619-y] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
234 Wang YR, Cangemi JR, Loftus EV Jr, Picco MF. Rate of early/missed colorectal cancers after colonoscopy in older patients with or without inflammatory bowel disease in the United States. Am J Gastroenterol 2013;108:444-9. [PMID: 23295277 DOI: 10.1038/ajg.2012.429] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 6.4] [Reference Citation Analysis]
235 Ording AG, Horváth-Puhó E, Erichsen R, Long MD, Baron JA, Lash TL, Sørensen HT. Five-year mortality in colorectal cancer patients with ulcerative colitis or Crohn's disease: a nationwide population-based cohort study. Inflamm Bowel Dis 2013;19:800-5. [PMID: 23435402 DOI: 10.1097/MIB.0b013e3182802af7] [Cited by in Crossref: 55] [Cited by in F6Publishing: 49] [Article Influence: 5.5] [Reference Citation Analysis]
236 Mescoli C, Albertoni L, D'incá R, Rugge M. Dysplasia in inflammatory bowel diseases. Dig Liver Dis 2013;45:186-94. [PMID: 22974564 DOI: 10.1016/j.dld.2012.07.013] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
237 Turk HF, Monk JM, Hou TY, Chapkin RS. Omega-3 Fatty Acids in Cancer Prevention and Control: A Membrane Perspective. Obesity, Inflammation and Cancer 2013. [DOI: 10.1007/978-1-4614-6819-6_12] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
238 Andújar I, Ríos JL, Giner RM, Miguel Cerdá J, Recio Mdel C. Beneficial effect of shikonin on experimental colitis induced by dextran sulfate sodium in BALB/c mice. Evid Based Complement Alternat Med 2012;2012:271606. [PMID: 23346196 DOI: 10.1155/2012/271606] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 3.5] [Reference Citation Analysis]
239 Lightfoot YL, Rehman HU, Myers AD, Mohamadzadeh M. Mitigating colon cancer with a novel strain of Lactobacillus acidophilus: a (re-)balancing act. Immunotherapy 2012;4:1087-9. [PMID: 23194356 DOI: 10.2217/imt.12.98] [Reference Citation Analysis]
240 Grivennikov SI. Inflammation and colorectal cancer: colitis-associated neoplasia. Semin Immunopathol. 2013;35:229-244. [PMID: 23161445 DOI: 10.1007/s00281-012-0352-6] [Cited by in Crossref: 343] [Cited by in F6Publishing: 368] [Article Influence: 31.2] [Reference Citation Analysis]
241 Ray K. Gut microbiota: Colorectal cancer-driven by inflammation and gut bacteria? Nat Rev Gastroenterol Hepatol 2012;9:558. [PMID: 22945445 DOI: 10.1038/nrgastro.2012.172] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
242 Tanaka T, Ishikawa H. Mast cells and inflammation-associated colorectal carcinogenesis. Semin Immunopathol 2013;35:245-54. [PMID: 22993030 DOI: 10.1007/s00281-012-0343-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
243 Merelli I, Viti F, Milanesi L. IBDsite: a Galaxy-interacting, integrative database for supporting inflammatory bowel disease high throughput data analysis. BMC Bioinformatics 2012;13 Suppl 14:S5. [PMID: 23095257 DOI: 10.1186/1471-2105-13-S14-S5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
244 Dyson JK, Rutter MD. Colorectal cancer in inflammatory bowel disease: What is the real magnitude of the risk? World J Gastroenterol 2012; 18(29): 3839-3848 [PMID: 22876036 DOI: 10.3748/wjg.v18.i29.3839] [Cited by in CrossRef: 146] [Cited by in F6Publishing: 159] [Article Influence: 13.3] [Reference Citation Analysis]
245 Tanaka T. Preclinical cancer chemoprevention studies using animal model of inflammation-associated colorectal carcinogenesis. Cancers (Basel) 2012;4:673-700. [PMID: 24213461 DOI: 10.3390/cancers4030673] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
246 Hirota CL, Moreau F, Iablokov V, Dicay M, Renaux B, Hollenberg MD, MacNaughton WK. Epidermal growth factor receptor transactivation is required for proteinase-activated receptor-2-induced COX-2 expression in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 2012;303:G111-9. [PMID: 22517768 DOI: 10.1152/ajpgi.00358.2011] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.7] [Reference Citation Analysis]
247 Tjalsma H, Boleij A, Marchesi JR, Dutilh BE. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol. 2012;10:575-582. [PMID: 22728587 DOI: 10.1038/nrmicro2819] [Cited by in Crossref: 484] [Cited by in F6Publishing: 518] [Article Influence: 44.0] [Reference Citation Analysis]
248 Shanahan F. Ulcerative Colitis. Textbook of Clinical Gastroenterology and Hepatology 2012. [DOI: 10.1002/9781118321386.ch49] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
249 Martini M, Ferrara AM, Giachelia M, Panieri E, Siminovitch K, Galeotti T, Larocca LM, Pani G. Association of the OCTN1/1672T variant with increased risk for colorectal cancer in young individuals and ulcerative colitis patients. Inflamm Bowel Dis 2012;18:439-48. [PMID: 21793125 DOI: 10.1002/ibd.21814] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
250 Hyun YS, Han DS, Lee AR, Eun CS, Youn J, Kim HY. Role of IL-17A in the development of colitis-associated cancer. Carcinogenesis. 2012;33:931-936. [PMID: 22354874 DOI: 10.1093/carcin/bgs106] [Cited by in Crossref: 130] [Cited by in F6Publishing: 134] [Article Influence: 11.8] [Reference Citation Analysis]
251 Boleij A, Tjalsma H. Gut bacteria in health and disease: a survey on the interface between intestinal microbiology and colorectal cancer. Biol Rev Camb Philos Soc. 2012;87:701-730. [PMID: 22296522 DOI: 10.1111/j.1469-185x.2012.00218.x] [Cited by in Crossref: 102] [Cited by in F6Publishing: 107] [Article Influence: 9.3] [Reference Citation Analysis]
252 Gong W, Lv N, Wang B, Chen Y, Huang Y, Pan W, Jiang B. Risk of ulcerative colitis-associated colorectal cancer in China: a multi-center retrospective study. Dig Dis Sci 2012;57:503-7. [PMID: 21938485 DOI: 10.1007/s10620-011-1890-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 3.9] [Reference Citation Analysis]
253 Baars JE, van der Woude CJ. So where is all the Cancer? Clinical Dilemmas in Inflammatory Bowel Disease 2012. [DOI: 10.1002/9781444342574.ch49] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
254 Ernst M, Ramsay RG. Colorectal cancer mouse models: integrating inflammation and the stroma. J Gastroenterol Hepatol 2012;27:39-50. [PMID: 22188027 DOI: 10.1111/j.1440-1746.2011.06883.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
255 Toma M, Beluşică L, Stavarachi M, Apostol P, Spandole S, Radu I, Cimponeriu D. Rating the environmental and genetic risk factors for colorectal cancer. J Med Life 2012;5:152-9. [PMID: 31803304] [Reference Citation Analysis]
256 Neri E, Mantarro A, Scandiffio R, Bemi P, Faggioni L, Bartolozzi C. MSCT of the Abdomen: Colon, Rectum and CT Colonography. Multislice-CT of the Abdomen 2012. [DOI: 10.1007/174_2012_539] [Reference Citation Analysis]
257 Li TW, Yang H, Peng H, Xia M, Mato JM, Lu SC. Effects of S-adenosylmethionine and methylthioadenosine on inflammation-induced colon cancer in mice. Carcinogenesis 2012;33:427-35. [PMID: 22159228 DOI: 10.1093/carcin/bgr295] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 4.5] [Reference Citation Analysis]
258 Di Sabatino A, Biancheri P, Rovedatti L, Macdonald TT, Corazza GR. Recent advances in understanding ulcerative colitis. Intern Emerg Med. 2012;7:103-111. [PMID: 22068230 DOI: 10.1007/s11739-011-0719-z] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
259 McClellan JL, Davis JM, Steiner JL, Day SD, Steck SE, Carmichael MD, Murphy EA. Intestinal inflammatory cytokine response in relation to tumorigenesis in the Apc(Min/+) mouse. Cytokine. 2012;57:113-119. [PMID: 22056354 DOI: 10.1016/j.cyto.2011.09.027] [Cited by in Crossref: 45] [Cited by in F6Publishing: 41] [Article Influence: 3.8] [Reference Citation Analysis]
260 Ren J, Wang Y, Gao Y, Mehta SB, Lee CG. FAT10 mediates the effect of TNF-α in inducing chromosomal instability. J Cell Sci 2011;124:3665-75. [PMID: 22025632 DOI: 10.1242/jcs.087403] [Cited by in Crossref: 53] [Cited by in F6Publishing: 56] [Article Influence: 4.4] [Reference Citation Analysis]
261 Subramanian V, Logan RF. Chemoprevention of colorectal cancer in inflammatory bowel disease. Best Pract Res Clin Gastroenterol 2011;25:593-606. [PMID: 22122774 DOI: 10.1016/j.bpg.2011.09.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.3] [Reference Citation Analysis]
262 Niu JK, Miao YL. Endoscopic diagnosis and treatment of ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2011; 19(20): 2153-2159 [DOI: 10.11569/wcjd.v19.i20.2153] [Reference Citation Analysis]
263 Mattar MC, Lough D, Pishvaian MJ, Charabaty A. Current management of inflammatory bowel disease and colorectal cancer. Gastrointest Cancer Res 2011;4:53-61. [PMID: 21673876] [Reference Citation Analysis]
264 Stallmach A, Hagel S, Gharbi A, Settmacher U, Hartmann M, Schmidt C, Bruns T. Medical and surgical therapy of inflammatory bowel disease in the elderly - prospects and complications. J Crohns Colitis 2011;5:177-88. [PMID: 21575879 DOI: 10.1016/j.crohns.2011.02.001] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 3.2] [Reference Citation Analysis]
265 Sprakes MB, Everett SM. Is the risk of inflammatory bowel disease-related colorectal carcinoma limited? Am J Gastroenterol 2011;106:999; author reply 999-1000. [PMID: 21540902 DOI: 10.1038/ajg.2011.12] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
266 Fletcher JG, Fidler JL, Bruining DH, Huprich JE. New concepts in intestinal imaging for inflammatory bowel diseases. Gastroenterology 2011;140:1795-806. [PMID: 21530746 DOI: 10.1053/j.gastro.2011.02.013] [Cited by in Crossref: 101] [Cited by in F6Publishing: 101] [Article Influence: 8.4] [Reference Citation Analysis]
267 Schiechl G, Bauer B, Fuss I, Lang SA, Moser C, Ruemmele P, Rose-John S, Neurath MF, Geissler EK, Schlitt HJ, Strober W, Fichtner-Feigl S. Tumor development in murine ulcerative colitis depends on MyD88 signaling of colonic F4/80+CD11b(high)Gr1(low) macrophages. J Clin Invest 2011;121:1692-708. [PMID: 21519141 DOI: 10.1172/JCI42540] [Cited by in Crossref: 66] [Cited by in F6Publishing: 70] [Article Influence: 5.5] [Reference Citation Analysis]
268 Pan SY, Morrison H. Epidemiology of cancer of the small intestine. World J Gastrointest Oncol 2011; 3(3): 33-42 [PMID: 21461167 DOI: 10.4251/wjgo.v3.i3.33] [Cited by in CrossRef: 109] [Cited by in F6Publishing: 131] [Article Influence: 9.1] [Reference Citation Analysis]
269 Mazzei JC, Zhou H, Brayfield BP, Hontecillas R, Bassaganya-Riera J, Schmelz EM. Suppression of intestinal inflammation and inflammation-driven colon cancer in mice by dietary sphingomyelin: importance of peroxisome proliferator-activated receptor γ expression. J Nutr Biochem 2011;22:1160-71. [PMID: 21295961 DOI: 10.1016/j.jnutbio.2010.09.017] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 5.1] [Reference Citation Analysis]
270 Baars JE, Looman CW, Steyerberg EW, Beukers R, Tan AC, Weusten BL, Kuipers EJ, van der Woude CJ. The risk of inflammatory bowel disease-related colorectal carcinoma is limited: results from a nationwide nested case-control study. Am J Gastroenterol 2011;106:319-28. [PMID: 21045815 DOI: 10.1038/ajg.2010.428] [Cited by in Crossref: 115] [Cited by in F6Publishing: 107] [Article Influence: 9.6] [Reference Citation Analysis]
271 Yang LP, Mccormack PL. MMX® Mesalazine: A Review of its Use in the Management of Mild to Moderate Ulcerative Colitis. Drugs 2011;71:221-35. [DOI: 10.2165/11205870-000000000-00000] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
272 Chalaris A, Garbers C, Rabe B, Rose-John S, Scheller J. The soluble Interleukin 6 receptor: generation and role in inflammation and cancer. Eur J Cell Biol. 2011;90:484-494. [PMID: 21145125 DOI: 10.1016/j.ejcb.2010.10.007] [Cited by in Crossref: 195] [Cited by in F6Publishing: 182] [Article Influence: 15.0] [Reference Citation Analysis]
273 Baars JE, Vogelaar L, Wolfhagen FH, Biermann K, Kuipers EJ, van der Woude CJ. A short course of corticosteroids prior to surveillance colonoscopy to decrease mucosal inflammation in inflammatory bowel disease patients: results from a randomized controlled trial. J Crohns Colitis 2010;4:661-8. [PMID: 21122577 DOI: 10.1016/j.crohns.2010.07.011] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
274 Kosmidis C, Efthimiadis C, Anthimidis G, Vasiliadou K, Tzeveleki I, Fotiadis P, Basdanis G. Small cell carcinoma in ulcerative colitis--new treatment option: a case report. World J Surg Oncol 2010;8:100. [PMID: 21087512 DOI: 10.1186/1477-7819-8-100] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
275 Jatoi I, Benson JR, Liau SS, Chen Y, Cisco RM, Norton JA, Moley JF, Khalifeh KW, Choti MA. The role of surgery in cancer prevention. Curr Probl Surg 2010;47:750-830. [PMID: 20816140 DOI: 10.1067/j.cpsurg.2010.06.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
276 Su JL, Liu ZJ. Mechanisms underlying development of ulcerative colitis-associated colorectal carcinoma. Shijie Huaren Xiaohua Zazhi 2010; 18(19): 2008-2012 [DOI: 10.11569/wcjd.v18.i19.2008] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
277 Terzić J, Grivennikov S, Karin E, Karin M. Inflammation and colon cancer. Gastroenterology 2010;138:2101-2114.e5. [PMID: 20420949 DOI: 10.1053/j.gastro.2010.01.058] [Cited by in Crossref: 1333] [Cited by in F6Publishing: 1393] [Article Influence: 102.5] [Reference Citation Analysis]
278 Chromik AM, Huss S, Osseili H, Daigeler A, Kersting S, Sülberg D, Mittelkötter U, Herdegen T, Uhl W, Müller AM. Oral administration of the anti-proliferative substance taurolidine has no impact on dextran sulfate sodium induced colitis-associated carcinogenesis in mice. J Carcinog 2010;9:5. [PMID: 20442801 DOI: 10.4103/1477-3163.62536] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
279 Kekilli M, Dagli U, Kalkan IH, Tunc B, Disibeyaz S, Ulker A, Sahin B. Low incidence of colorectal dysplasia and cancer among patients with ulcerative colitis: a Turkish referral centre study. Scand J Gastroenterol 2010;45:434-9. [PMID: 20085438 DOI: 10.3109/00365520903540830] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
280 Stallmach A, Hagel S, Bruns T. Adverse effects of biologics used for treating IBD. Best Pract Res Clin Gastroenterol 2010;24:167-82. [PMID: 20227030 DOI: 10.1016/j.bpg.2010.01.002] [Cited by in Crossref: 140] [Cited by in F6Publishing: 144] [Article Influence: 10.8] [Reference Citation Analysis]
281 Calabrese P, Shibata D. A simple algebraic cancer equation: calculating how cancers may arise with normal mutation rates. BMC Cancer 2010;10:3. [PMID: 20051132 DOI: 10.1186/1471-2407-10-3] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 3.2] [Reference Citation Analysis]
282 Pastorelli L, Pizarro TT, Cominelli F, Vecchi M. Emerging drugs for the treatment of ulcerative colitis. Expert Opin Emerg Drugs 2009;14:505-21. [PMID: 19656075 DOI: 10.1517/14728210903146882] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
283 Kraus S, Arber N. Inflammation and colorectal cancer. Curr Opin Pharmacol 2009;9:405-10. [PMID: 19589728 DOI: 10.1016/j.coph.2009.06.006] [Cited by in Crossref: 193] [Cited by in F6Publishing: 182] [Article Influence: 13.8] [Reference Citation Analysis]
284 Carter AB, Misyak SA, Hontecillas R, Bassaganya-Riera J. Dietary modulation of inflammation-induced colorectal cancer through PPARγ. PPAR Res 2009;2009:498352. [PMID: 19390648 DOI: 10.1155/2009/498352] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
285 Leong RW, Koo JH. Colorectal cancer in inflammatory bowel disease. J Gastroenterol Hepatol 2009;24:503-5. [PMID: 19368629 DOI: 10.1111/j.1440-1746.2009.05790.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
286 Bonner WM, Redon CE, Dickey JS, Nakamura AJ, Sedelnikova OA, Solier S, Pommier Y. GammaH2AX and cancer. Nat Rev Cancer 2008;8:957-67. [PMID: 19005492 DOI: 10.1038/nrc2523] [Cited by in Crossref: 1206] [Cited by in F6Publishing: 1264] [Article Influence: 80.4] [Reference Citation Analysis]